Global Biopharma Layoffs November 2025LayoffsThis article tracks recent biotech and pharma layoffs, including major workforce cuts at Novo Nordisk, Takeda, GSK, Pharming, and others, as companies restructure operations, streamline pipelines, and refocus resources amid shifting market conditions.
Novartis Deepens China Ties with Eye Drug PactNovatisNovartis has expanded its strategic collaboration with Shanghai Pharma to promote ophthalmic drugs in China, aiming to enhance market coverage and accelerate growth as it targets a top-three pharma position in the country.
GSK's Blenrep Gains EU Backing in New Combo UseGSKGSK’s Blenrep gains CHMP recommendation for combination use in multiple myeloma, marking a comeback after U.S. withdrawal. Novartis withdraws Lutathera EU expansion. Other CHMP approvals and rejections detailed.
Nuclear Medicine Titans: The Battle in a $10 Billion MarketBayerExplore how pharma giants like Novartis, Bayer, AstraZeneca, BMS, and Eli Lilly are battling for dominance in the booming $10B radiopharmaceutical market with cutting-edge therapies and strategic acquisitions.
